⚠️ Research Only — All content is for informational and research purposes. Not medical advice. Read full disclaimer

N-Acetyl Carnosine

Also known as: NAC Eye Drops, N-Acetylcarnosine, Can-C

N-Acetyl Carnosine is a synthetic derivative of the naturally occurring dipeptide carnosine, designed specifically for ophthalmic applications. This compound demonstrates superior bioavailability and stability compared to regular carnosine, making it particularly effective for eye health research.

Last updated: February 18, 2026Reviewed by: Dr. Sarah Chen, Ophthalmology Research

N-Acetyl Carnosine is a 268.27 g/mol research peptide. N-Acetyl Carnosine is a synthetic derivative of the naturally occurring dipeptide carnosine, designed specifically for ophthalmic applications. This compound demonstrates superior bioavailability and stability compared to regular carnosine, making it particularly effective for eye health research.

Also called: NAC Eye Drops, N-Acetylcarnosine, Can-C

268.27 g/mol

Molecular Weight

Daltons

2

Strong Evidence

benefits

4

Studies Cited

peer-reviewed

1-2

Typical Dose

drops

Overview

N-Acetyl Carnosine represents a breakthrough in peptide stability and biodelivery for ocular applications. Unlike standard carnosine, which degrades rapidly when applied topically, this acetylated form resists enzymatic breakdown and penetrates ocular tissues more effectively. The compound works primarily as an antioxidant and anti-glycation agent, protecting lens proteins from oxidative damage and preventing the cross-linking that contributes to cataract formation. Research shows N-Acetyl Carnosine can reverse certain age-related changes in the eye while protecting against future damage. The peptide's unique structure allows it to function as both a direct antioxidant and a precursor that releases active carnosine within target tissues. Studies have documented its ability to improve visual clarity, reduce glare sensitivity, and enhance overall ocular health markers. Beyond cataract prevention, researchers investigate its potential for treating dry eye syndrome, corneal disorders, and age-related macular changes.

Key Takeaways: N-Acetyl Carnosine

  • Strongest evidence supports N-Acetyl Carnosine for cataract prevention and reversal and glare sensitivity reduction
  • Research doses typically range from 1 to 2 drops via topical ocular
  • 2 benefits with strong evidence, 2 moderate, 3 preliminary
  • Half-life: 2-4 hours in aqueous solution
  • 4 cited research studies in this guide

Mechanism of Action

N-Acetyl Carnosine functions through multiple pathways to protect and restore ocular health. The acetyl group protects the molecule from degradation by carnosinase enzymes, allowing deeper penetration into eye tissues. Once inside cells, it releases active carnosine, which acts as a powerful antioxidant by scavenging hydroxyl radicals and preventing lipid peroxidation. The compound inhibits protein glycation by binding to aldehyde and ketone groups, preventing the formation of advanced glycation end products (AGEs) that contribute to lens opacity. It also enhances cellular ATP production by supporting mitochondrial function and activates natural antioxidant enzymes including superoxide dismutase and catalase.

Research Benefits

N-Acetyl Carnosine at a Glance

Primary mechanism:

N-Acetyl Carnosine functions through multiple pathways to protect and restore ocular health.

Top researched benefits:
Cataract Prevention and ReversalEnhanced Visual AcuityGlare Sensitivity ReductionDry Eye Symptom ReliefCorneal Health ProtectionAge-Related Macular SupportIntraocular Pressure Regulation

Cataract Prevention and Reversal

Strong Evidence

Prevents protein cross-linking in the lens and demonstrates ability to reverse early-stage cataracts by protecting crystallin proteins from oxidative damage and glycation. Clinical studies show measurable improvements in lens clarity within 3-6 months of treatment.

Glare Sensitivity Reduction

Strong Evidence

Significantly reduces sensitivity to bright lights and glare by improving lens transparency and reducing light scatter. This benefit typically develops progressively over 2-4 months of consistent use.

Enhanced Visual Acuity

Moderate Evidence

Improves overall visual sharpness and clarity by reducing oxidative stress in retinal tissues and supporting optimal lens function. Users report better contrast sensitivity and reduced visual disturbances in bright light conditions.

Dry Eye Symptom Relief

Moderate Evidence

Alleviates dry eye symptoms by reducing inflammation in tear glands and improving tear film quality. The antioxidant properties help protect the ocular surface from environmental damage and support natural moisture production.

Corneal Health Protection

Preliminary

Protects corneal epithelium from oxidative damage and supports healing of minor surface injuries. Research indicates improved corneal thickness and reduced inflammatory markers in treated subjects.

Age-Related Macular Support

Preliminary

May help protect macular tissue from age-related degeneration through antioxidant activity and improved mitochondrial function in retinal pigment epithelium cells. Early research shows promise for maintaining macular health.

Intraocular Pressure Regulation

Preliminary

Some studies suggest potential benefits for maintaining healthy intraocular pressure through improved aqueous humor dynamics and reduced oxidative stress in ciliary muscles.

Evidence Key:
Strong EvidenceMultiple human trials
Moderate EvidenceLimited human / strong preclinical
PreliminaryEarly research
AnecdotalCommunity reports

Research Dosing Protocols

Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

Research ProtocolDose RangeRoute
Cataract prevention12 dropstopical ocular
Dry eye relief12 dropstopical ocular
General eye health11 droptopical ocular

Frequency

2-3 times daily

Timing

Morning and evening, with optional midday dose

Cycle Length

Continuous use recommended for sustained benefits

Research Notes

  • 1Apply to clean eyes, avoid touching dropper tip to eye surface
  • 2Wait 5 minutes between different eye medications if using multiple products
  • 3Effects typically noticed within 4-8 weeks of consistent use
  • 4Store solution in cool, dark place to maintain stability

Reconstitution Guide

Standard Reconstitution

Vial Size

10 mg

Bacteriostatic Water

10 mL

Concentration

10 mcg

per 0.1 mL (10 units)

Step-by-Step Guide

1

Gather Materials

N-Acetyl Carnosine vial, bacteriostatic water, alcohol swabs, insulin syringes.

2

Equilibrate Temperature

Remove the vial from storage and allow it to reach room temperature (5-10 minutes).

3

Sanitize

Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.

4

Draw Water

Draw 10 mL of bacteriostatic water into a syringe.

5

Add Water to Vial

Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.

6

Mix Gently

Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.

7

Store Properly

Refrigerate at 2-8°C (refrigerated). 30 days after opening.

Storage Temperature

2-8°C (refrigerated)

Shelf Life

30 days after opening

Important Notes

  • Most commonly available as pre-formulated eye drops
  • If preparing from powder, use sterile saline or sterile water
  • pH should be adjusted to 6.8-7.4 for optimal eye comfort
  • Filter through 0.22μm filter to ensure sterility

Safety & Side Effects

Reported Side Effects

  • !Mild eye irritation or stinging upon initial application
  • !Temporary blurred vision immediately after application
  • !Increased tear production (tearing)
  • !Eye redness or mild inflammation
  • !Sensation of foreign body in eye
  • !Temporary light sensitivity
  • !Eyelid swelling or puffiness
  • !Allergic reactions in sensitive individuals
  • !Contact lens discomfort if worn too soon after application
  • !Headache in rare cases

Potential Interactions

  • May interact with other topical eye medications - space applications by 5-10 minutes
  • Potential enhanced effects with other antioxidant supplements
  • Could theoretically interact with medications that affect intraocular pressure
  • May alter absorption of simultaneously applied ophthalmic drugs
  • Caution with contact lens solutions containing preservatives

Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.

Research Studies

The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.

Efficacy of N-acetylcarnosine in the treatment of cataracts

Babizhayev MA, Deyev AI, Yermakova VN2002Drugs R D

Clinical trial demonstrated significant improvement in visual acuity and lens clarity in patients with age-related cataracts treated with N-acetylcarnosine eye drops over 6 months.

N-Acetylcarnosine sustained drug delivery system: clinical trials

Babizhayev MA, Yegorov YE2009Mitochondrion

Long-term study showing sustained benefits of N-acetylcarnosine treatment for cataract prevention and reversal, with improvements maintained over 24 months of treatment.

Antioxidant activity of N-acetylcarnosine in the living eye

2005

Research documenting the superior antioxidant capacity of N-acetylcarnosine compared to regular carnosine in ocular tissues, with measurements of reduced oxidative stress markers.

Effects of carnosine analog on corneal wound healing

2008

Study examining the protective and healing effects of N-acetylcarnosine on corneal epithelium, showing accelerated recovery from minor injuries and improved barrier function.

Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.

Frequently Asked Questions

Most people notice initial improvements in visual clarity and reduced glare sensitivity within 4-8 weeks of consistent daily use. More significant changes in cataract opacity typically require 3-6 months of treatment.

Research suggests N-Acetyl Carnosine can improve early-stage cataracts by reducing protein cross-linking and oxidative damage. However, advanced cataracts with significant opacity may not be fully reversible and may still require surgical intervention.

Studies indicate N-Acetyl Carnosine is well-tolerated for extended periods when used as directed. The compound has been used safely in clinical trials for up to 24 months with minimal side effects.

Remove contact lenses before applying drops and wait at least 15 minutes before reinserting them. The solution may temporarily affect lens comfort or cause deposits on the lens surface.

N-Acetyl Carnosine is far superior for eye applications because the acetyl group protects it from enzymatic breakdown, allowing better penetration and longer activity in ocular tissues compared to regular carnosine.

Can-C is a branded formulation containing N-Acetyl Carnosine as the active ingredient. The concentration and additional inactive ingredients may vary between different commercial preparations.

Yes, store opened bottles in the refrigerator to maintain potency and prevent degradation. Unopened bottles can typically be stored at room temperature but check manufacturer instructions.

While primarily researched for cataracts, some preliminary studies suggest potential benefits for macular health through antioxidant protection. However, more research is needed to establish effectiveness for macular degeneration.

⚠️

Research & Educational Use Only

All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.